主要股东
注:以下部分股东代表特定权益共同体,直接或间接持有上市公司股份
| 序号 | 股东名称 | 是否机构 | 持股数(股) | 持股比例 | 持股变动数(股) | 持股数变动比例 | 投票权比例 |
|---|---|---|---|---|---|---|---|
| 1 | Rebecca Taub | 否 | 214.00万 | 11.70% |
|
|
-- |
| 2 | Paul A. Friedman | 否 | 214.00万 | 11.70% |
|
|
-- |
| 3 | Fred B. Craves | 否 | 204.96万 | 11.21% |
|
|
-- |
| 4 | Entities Affiliated with Avoro Capital Advisors LLC | 是 | 166.00万 | 9.08% | 新增 | 新增 | -- |
| 5 | Entities Affiliated with Baker Bros. Advisors LP | 是 | 154.51万 | 8.45% | 新增 | 新增 | -- |
| 6 | Entities Affiliated with Bay City Capital LLC | 是 | 151.18万 | 8.27% | 新增 | 新增 | -- |
| 7 | Entities Affiliated with The Vanguard Group | 是 | 126.64万 | 6.93% | 新增 | 新增 | -- |
| 8 | Entities Affiliated with State Street Corporation | 是 | 126.10万 | 6.90% | 新增 | 新增 | -- |
| 9 | Entities Affiliated with BlackRock, Inc. | 是 | 98.66万 | 5.40% | 新增 | 新增 | -- |
内部人交易
| 日期 | 股东名称 | 变动股数(万股) | 交易后持股数量(万股) | 交易价格 | 是否直接持有 | 内部人类型 |
|---|---|---|---|---|---|---|
| 2025-12-10 | Taub Rebecca |
|
46.10 | 555.39 | 是 | -- |
| 2025-12-10 | Taub Rebecca |
|
45.56 | 0.00 | 是 | -- |
| 2025-12-10 | Taub Rebecca |
|
47.97 | 15.80 | 是 | -- |
| 2025-12-10 | Taub Rebecca |
|
47.92 | 547.76 | 是 | -- |
| 2025-12-10 | Taub Rebecca |
|
47.88 | 548.56 | 是 | -- |
| 2025-12-10 | Taub Rebecca |
|
47.83 | 550.07 | 是 | -- |
| 2025-12-10 | Taub Rebecca |
|
47.36 | 550.99 | 是 | -- |
| 2025-12-10 | Taub Rebecca |
|
46.92 | 551.85 | 是 | -- |
| 2025-12-10 | Taub Rebecca |
|
46.54 | 552.81 | 是 | -- |
| 2025-12-10 | Taub Rebecca |
|
46.23 | 553.88 | 是 | -- |
| 2025-12-10 | Taub Rebecca |
|
46.12 | 554.84 | 是 | -- |
| 2025-12-10 | FRIEDMAN PAUL A |
|
21.20 | 15.80 | 是 | -- |
| 2025-12-10 | FRIEDMAN PAUL A |
|
21.13 | 547.75 | 是 | -- |
| 2025-12-10 | FRIEDMAN PAUL A |
|
21.08 | 548.51 | 是 | -- |
| 2025-12-10 | FRIEDMAN PAUL A |
|
21.04 | 549.99 | 是 | -- |
| 2025-12-10 | FRIEDMAN PAUL A |
|
20.61 | 550.93 | 是 | -- |
| 2025-12-10 | FRIEDMAN PAUL A |
|
19.89 | 551.67 | 是 | -- |
| 2025-12-10 | FRIEDMAN PAUL A |
|
19.34 | 552.74 | 是 | -- |
| 2025-12-10 | FRIEDMAN PAUL A |
|
18.84 | 553.83 | 是 | -- |
| 2025-12-10 | FRIEDMAN PAUL A |
|
18.73 | 555.00 | 是 | -- |
| 2025-12-10 | FRIEDMAN PAUL A |
|
18.72 | 555.39 | 是 | -- |
| 2025-12-03 | Sibold William John |
|
15.25 | -- | 是 | President and CEO |
| 2025-12-03 | Sibold William John |
|
15.01 | 575.34 | 是 | President and CEO |
| 2025-12-02 | Dier Mardi |
|
1.46 | 251.63 | 是 | EVP and CFO |
| 2025-12-02 | Dier Mardi |
|
1.43 | 570.39 | 是 | EVP and CFO |
| 2025-12-02 | Dier Mardi |
|
1.39 | 571.99 | 是 | EVP and CFO |
| 2025-12-02 | Dier Mardi |
|
1.35 | 573.02 | 是 | EVP and CFO |
| 2025-12-02 | Dier Mardi |
|
1.28 | 574.00 | 是 | EVP and CFO |
| 2025-12-02 | Dier Mardi |
|
1.27 | 574.95 | 是 | EVP and CFO |
| 2025-12-02 | Dier Mardi |
|
1.25 | 576.15 | 是 | EVP and CFO |
| 2025-12-02 | Dier Mardi |
|
1.21 | 577.81 | 是 | EVP and CFO |
| 2025-12-02 | Dier Mardi |
|
1.19 | 578.83 | 是 | EVP and CFO |
| 2025-12-02 | Dier Mardi |
|
1.14 | 579.85 | 是 | EVP and CFO |
| 2025-12-02 | Dier Mardi |
|
1.12 | 585.44 | 是 | EVP and CFO |
| 2025-12-02 | Dier Mardi |
|
1.09 | 587.85 | 是 | EVP and CFO |
| 2025-12-02 | Dier Mardi |
|
1.08 | 589.65 | 是 | EVP and CFO |
| 2025-12-02 | Dier Mardi |
|
1.06 | 590.37 | 是 | EVP and CFO |
| 2025-11-21 | Huntsman Carole |
|
1.11 | 550.97 | 是 | Chief Commercial Officer |
| 2025-11-21 | Huntsman Carole |
|
1.10 | 547.27 | 是 | Chief Commercial Officer |
| 2025-11-21 | Huntsman Carole |
|
1.08 | 548.71 | 是 | Chief Commercial Officer |
| 2025-11-21 | Huntsman Carole |
|
1.06 | 552.38 | 是 | Chief Commercial Officer |
| 2025-11-21 | Huntsman Carole |
|
1.04 | 556.04 | 是 | Chief Commercial Officer |
| 2025-11-21 | Huntsman Carole |
|
1.02 | 559.60 | 是 | Chief Commercial Officer |
| 2025-11-13 | Levy Richard S |
|
2.37 | 7.36 | 是 | -- |
| 2025-11-13 | Levy Richard S |
|
2.97 | 16.46 | 是 | -- |
| 2025-11-13 | Levy Richard S |
|
2.96 | 514.67 | 是 | -- |
| 2025-11-13 | Levy Richard S |
|
2.86 | 515.64 | 是 | -- |
| 2025-11-13 | Levy Richard S |
|
2.80 | 517.51 | 是 | -- |
| 2025-11-13 | Levy Richard S |
|
2.72 | 518.53 | 是 | -- |
| 2025-11-13 | Levy Richard S |
|
2.58 | 519.67 | 是 | -- |
| 2025-11-13 | Levy Richard S |
|
2.55 | 520.68 | 是 | -- |
| 2025-11-13 | Levy Richard S |
|
2.44 | 521.79 | 是 | -- |
| 2025-11-13 | Levy Richard S |
|
2.30 | 522.70 | 是 | -- |
| 2025-11-13 | Levy Richard S |
|
2.22 | 523.66 | 是 | -- |
| 2025-11-13 | Levy Richard S |
|
2.20 | 524.49 | 是 | -- |
| 2025-11-13 | Levy Richard S |
|
2.19 | 526.68 | 是 | -- |
| 2025-11-13 | Levy Richard S |
|
2.17 | 527.85 | 是 | -- |
| 2025-11-13 | Levy Richard S |
|
2.12 | 528.60 | 是 | -- |
| 2025-11-05 | BATE KENNETH |
|
0.81 | 9.45 | 是 | -- |
| 2025-11-05 | BATE KENNETH |
|
1.81 | 303.79 | 是 | -- |
| 2025-11-05 | BATE KENNETH |
|
1.92 | 280.04 | 是 | -- |
| 2025-11-05 | BATE KENNETH |
|
1.74 | 480.24 | 是 | -- |
| 2025-11-05 | BATE KENNETH |
|
1.42 | 481.13 | 是 | -- |
| 2025-11-05 | BATE KENNETH |
|
1.29 | 482.41 | 是 | -- |
| 2025-11-05 | BATE KENNETH |
|
1.08 | 483.41 | 是 | -- |
| 2025-11-05 | BATE KENNETH |
|
0.89 | 484.78 | 是 | -- |
| 2025-11-05 | BATE KENNETH |
|
0.79 | 485.54 | 是 | -- |
| 2025-11-05 | BATE KENNETH |
|
0.71 | 486.73 | 是 | -- |
| 2025-11-05 | BATE KENNETH |
|
0.43 | 487.49 | 是 | -- |
| 2025-11-05 | BATE KENNETH |
|
0.36 | 489.09 | 是 | -- |
| 2025-11-05 | BATE KENNETH |
|
0.27 | 489.95 | 是 | -- |
| 2025-09-09 | Sibold William John |
|
10.25 | 445.63 | 是 | President and CEO |
| 2025-08-21 | Sibold William John |
|
11.09 | 400.03 | 是 | President and CEO |
| 2025-08-21 | Sibold William John |
|
10.98 | 401.00 | 是 | President and CEO |
| 2025-08-18 | Kelley Shannon T |
|
1.00 | 358.66 | 是 | General Counsel |
| 2025-08-18 | Kelley Shannon T |
|
0.99 | 369.64 | 是 | General Counsel |
| 2025-08-18 | Kelley Shannon T |
|
0.95 | 372.44 | 是 | General Counsel |
| 2025-08-18 | Kelley Shannon T |
|
0.92 | 375.75 | 是 | General Counsel |
| 2025-08-15 | BATE KENNETH |
|
1.03 | 363.41 | 是 | -- |
| 2025-08-15 | BATE KENNETH |
|
0.78 | 364.24 | 是 | -- |
| 2025-08-15 | BATE KENNETH |
|
0.52 | 365.33 | 是 | -- |
| 2025-08-15 | BATE KENNETH |
|
0.46 | 366.14 | 是 | -- |
| 2025-08-15 | BATE KENNETH |
|
0.35 | 367.63 | 是 | -- |
| 2025-08-15 | BATE KENNETH |
|
0.26 | 368.56 | 是 | -- |
| 2025-08-15 | BATE KENNETH |
|
1.26 | 16.46 | 是 | -- |
| 2025-08-13 | FRIEDMAN PAUL A |
|
31.43 | 359.31 | 是 | -- |
| 2025-08-13 | FRIEDMAN PAUL A |
|
31.63 | 9.45 | 是 | -- |
| 2025-08-13 | FRIEDMAN PAUL A |
|
31.47 | 358.23 | 是 | -- |
| 2025-08-13 | FRIEDMAN PAUL A |
|
31.11 | 360.27 | 是 | -- |
| 2025-08-13 | FRIEDMAN PAUL A |
|
30.94 | 361.13 | 是 | -- |
| 2025-08-13 | FRIEDMAN PAUL A |
|
30.79 | 362.29 | 是 | -- |
| 2025-08-13 | FRIEDMAN PAUL A |
|
30.53 | 363.08 | 是 | -- |
| 2025-08-13 | FRIEDMAN PAUL A |
|
30.18 | 364.02 | 是 | -- |
| 2025-08-13 | FRIEDMAN PAUL A |
|
30.01 | 365.19 | 是 | -- |
| 2025-08-13 | FRIEDMAN PAUL A |
|
29.69 | 366.22 | 是 | -- |
| 2025-08-13 | FRIEDMAN PAUL A |
|
28.98 | 367.31 | 是 | -- |
| 2025-08-13 | FRIEDMAN PAUL A |
|
28.30 | 368.34 | 是 | -- |
| 2025-08-13 | FRIEDMAN PAUL A |
|
27.50 | 369.44 | 是 | -- |
| 2025-08-13 | FRIEDMAN PAUL A |
|
26.72 | 370.44 | 是 | -- |
| 2025-08-13 | FRIEDMAN PAUL A |
|
24.45 | 371.53 | 是 | -- |
| 2025-08-13 | FRIEDMAN PAUL A |
|
21.55 | 372.39 | 是 | -- |
| 2025-08-13 | FRIEDMAN PAUL A |
|
19.13 | 373.35 | 是 | -- |
| 2025-08-13 | FRIEDMAN PAUL A |
|
18.72 | 374.38 | 是 | -- |
| 2025-08-11 | FRIEDMAN PAUL A |
|
19.04 | 9.45 | 是 | -- |
| 2025-08-11 | FRIEDMAN PAUL A |
|
18.75 | 350.19 | 是 | -- |
| 2025-08-11 | FRIEDMAN PAUL A |
|
18.72 | 351.04 | 是 | -- |
| 2025-08-11 | FRIEDMAN PAUL A |
|
23.08 | 9.45 | 是 | -- |
| 2025-08-11 | FRIEDMAN PAUL A |
|
22.75 | 350.93 | 是 | -- |
| 2025-08-11 | FRIEDMAN PAUL A |
|
22.43 | 351.59 | 是 | -- |
| 2025-08-11 | FRIEDMAN PAUL A |
|
22.29 | 352.61 | 是 | -- |
| 2025-08-11 | FRIEDMAN PAUL A |
|
21.81 | 354.06 | 是 | -- |
| 2025-08-11 | FRIEDMAN PAUL A |
|
21.16 | 355.00 | 是 | -- |
| 2025-08-11 | FRIEDMAN PAUL A |
|
20.63 | 355.97 | 是 | -- |
| 2025-08-11 | FRIEDMAN PAUL A |
|
20.12 | 356.94 | 是 | -- |
| 2025-08-11 | FRIEDMAN PAUL A |
|
19.28 | 357.93 | 是 | -- |
| 2025-08-11 | FRIEDMAN PAUL A |
|
18.78 | 358.83 | 是 | -- |
| 2025-08-11 | FRIEDMAN PAUL A |
|
18.72 | 359.81 | 是 | -- |
| 2025-08-11 | Taub Rebecca |
|
46.42 | 9.45 | 是 | -- |
| 2025-08-11 | Taub Rebecca |
|
46.13 | 350.18 | 是 | -- |
| 2025-08-11 | Taub Rebecca |
|
46.10 | 351.02 | 是 | -- |
| 2025-08-11 | Taub Rebecca |
|
50.43 | 9.45 | 是 | -- |
| 2025-08-11 | Taub Rebecca |
|
50.07 | 350.87 | 是 | -- |
| 2025-08-11 | Taub Rebecca |
|
49.79 | 351.60 | 是 | -- |
| 2025-08-11 | Taub Rebecca |
|
49.67 | 352.45 | 是 | -- |
| 2025-08-11 | Taub Rebecca |
|
49.21 | 354.04 | 是 | -- |
| 2025-08-11 | Taub Rebecca |
|
48.56 | 354.97 | 是 | -- |
| 2025-08-11 | Taub Rebecca |
|
47.99 | 355.95 | 是 | -- |
| 2025-08-11 | Taub Rebecca |
|
47.50 | 356.88 | 是 | -- |
| 2025-08-11 | Taub Rebecca |
|
46.83 | 357.85 | 是 | -- |
| 2025-08-11 | Taub Rebecca |
|
46.17 | 358.81 | 是 | -- |
| 2025-08-11 | Taub Rebecca |
|
46.10 | 359.71 | 是 | -- |
| 2025-08-01 | Brennan Daniel J. |
|
0.10 | 0.00 | 是 | -- |
| 2025-07-18 | FRIEDMAN PAUL A |
|
18.86 | 9.45 | 是 | -- |
| 2025-07-18 | FRIEDMAN PAUL A |
|
18.72 | 350.03 | 是 | -- |
| 2025-07-18 | Taub Rebecca |
|
46.20 | 9.45 | 是 | -- |
| 2025-07-18 | Taub Rebecca |
|
46.10 | 350.01 | 是 | -- |
| 2025-07-16 | Taub Rebecca |
|
48.75 | 9.45 | 是 | -- |
| 2025-07-16 | Taub Rebecca |
|
48.15 | 350.19 | 是 | -- |
| 2025-07-16 | Taub Rebecca |
|
47.96 | 351.37 | 是 | -- |
| 2025-07-16 | Taub Rebecca |
|
47.72 | 352.64 | 是 | -- |
| 2025-07-16 | Taub Rebecca |
|
47.47 | 353.82 | 是 | -- |
| 2025-07-16 | Taub Rebecca |
|
46.89 | 354.61 | 是 | -- |
| 2025-07-16 | Taub Rebecca |
|
46.24 | 355.61 | 是 | -- |
| 2025-07-16 | Taub Rebecca |
|
46.10 | 356.52 | 是 | -- |
| 2025-07-16 | Taub Rebecca |
|
46.37 | 9.45 | 是 | -- |
| 2025-07-16 | Taub Rebecca |
|
46.16 | 350.09 | 是 | -- |
| 2025-07-16 | Taub Rebecca |
|
46.10 | 351.50 | 是 | -- |
| 2025-07-16 | FRIEDMAN PAUL A |
|
18.72 | 351.57 | 是 | -- |
| 2025-07-16 | FRIEDMAN PAUL A |
|
21.33 | 9.45 | 是 | -- |
| 2025-07-16 | FRIEDMAN PAUL A |
|
20.78 | 350.17 | 是 | -- |
| 2025-07-16 | FRIEDMAN PAUL A |
|
20.54 | 351.38 | 是 | -- |
| 2025-07-16 | FRIEDMAN PAUL A |
|
20.33 | 352.67 | 是 | -- |
| 2025-07-16 | FRIEDMAN PAUL A |
|
20.10 | 353.82 | 是 | -- |
| 2025-07-16 | FRIEDMAN PAUL A |
|
19.41 | 354.65 | 是 | -- |
| 2025-07-16 | FRIEDMAN PAUL A |
|
18.84 | 355.61 | 是 | -- |
| 2025-07-16 | FRIEDMAN PAUL A |
|
18.72 | 356.62 | 是 | -- |
| 2025-07-16 | FRIEDMAN PAUL A |
|
18.99 | 9.45 | 是 | -- |
| 2025-07-16 | FRIEDMAN PAUL A |
|
18.79 | 350.10 | 是 | -- |
| 2025-06-20 | FRIEDMAN PAUL A |
|
18.72 | 0.00 | 是 | -- |
| 2025-06-20 | Daly James M |
|
0.26 | 0.00 | 是 | -- |
| 2025-06-20 | FOUSE JACQUALYN A |
|
0.11 | 0.00 | 是 | -- |
| 2025-06-20 | Levy Richard S |
|
2.12 | 0.00 | 是 | -- |
| 2025-06-20 | BATE KENNETH |
|
0.26 | 0.00 | 是 | -- |
| 2025-05-15 | Soergel David |
|
0.75 | 0.00 | 是 | Chief Medical Officer |
| 2025-04-10 | Levy Richard S |
|
2.05 | 65.06 | 是 | -- |
| 2025-03-12 | CRAVES FRED B |
|
35.18 | 65.06 | 是 | -- |
| 2025-03-12 | CRAVES FRED B |
|
35.78 | 111.06 | 是 | -- |
| 2025-03-12 | CRAVES FRED B |
|
35.62 | 330.54 | 是 | -- |
| 2025-03-12 | CRAVES FRED B |
|
35.35 | 331.36 | 是 | -- |
| 2025-03-12 | CRAVES FRED B |
|
35.11 | 332.38 | 是 | -- |
| 2025-03-12 | CRAVES FRED B |
|
35.03 | 333.66 | 是 | -- |
| 2025-03-12 | CRAVES FRED B |
|
35.01 | 334.97 | 是 | -- |
| 2025-03-12 | CRAVES FRED B |
|
35.78 | 65.06 | 是 | -- |
| 2025-03-12 | CRAVES FRED B |
|
35.59 | 322.45 | 是 | -- |
| 2025-03-12 | CRAVES FRED B |
|
35.42 | 323.47 | 是 | -- |
| 2025-03-12 | CRAVES FRED B |
|
35.33 | 324.69 | 是 | -- |
| 2025-03-12 | CRAVES FRED B |
|
35.25 | 325.63 | 是 | -- |
| 2025-03-12 | CRAVES FRED B |
|
35.15 | 327.63 | 是 | -- |
| 2025-03-12 | CRAVES FRED B |
|
35.11 | 328.68 | 是 | -- |
| 2025-03-12 | CRAVES FRED B |
|
35.02 | 329.86 | 是 | -- |
| 2025-03-10 | FOUSE JACQUALYN A |
|
0.09 | 0.00 | 是 | -- |
| 2025-03-10 | Dier Mardi |
|
1.04 | 323.04 | 是 | SVP and CFO |
| 2025-03-05 | Huntsman Carole |
|
1.20 | 0.00 | 是 | Chief Commercial Officer |
| 2025-03-05 | Sibold William John |
|
11.74 | 0.00 | 是 | President and CEO |
| 2025-03-05 | Dier Mardi |
|
1.07 | 0.00 | 是 | SVP and CFO |
| 2025-03-05 | Waltermire Robert E. |
|
1.06 | 87.92 | 是 | Senior VP, Chief Pharma Dev. |
| 2025-03-05 | Waltermire Robert E. |
|
1.78 | 87.09 | 是 | Senior VP, Chief Pharma Dev. |
| 2025-03-05 | Waltermire Robert E. |
|
1.69 | 335.15 | 是 | Senior VP, Chief Pharma Dev. |
| 2025-03-05 | Waltermire Robert E. |
|
1.52 | 336.78 | 是 | Senior VP, Chief Pharma Dev. |
| 2025-03-05 | Waltermire Robert E. |
|
1.40 | 338.09 | 是 | Senior VP, Chief Pharma Dev. |
| 2025-03-05 | Waltermire Robert E. |
|
0.51 | 343.85 | 是 | Senior VP, Chief Pharma Dev. |
| 2025-03-05 | Waltermire Robert E. |
|
0.37 | 344.76 | 是 | Senior VP, Chief Pharma Dev. |
| 2025-03-05 | Waltermire Robert E. |
|
0.58 | 0.00 | 是 | Senior VP, Chief Pharma Dev. |
| 2025-03-05 | Waltermire Robert E. |
|
1.36 | 339.68 | 是 | Senior VP, Chief Pharma Dev. |
| 2025-03-05 | Waltermire Robert E. |
|
1.20 | 340.75 | 是 | Senior VP, Chief Pharma Dev. |
| 2025-03-05 | Waltermire Robert E. |
|
1.09 | 341.84 | 是 | Senior VP, Chief Pharma Dev. |
| 2025-03-05 | Waltermire Robert E. |
|
0.98 | 342.90 | 是 | Senior VP, Chief Pharma Dev. |
| 2025-03-05 | Kelley Shannon T |
|
1.05 | 0.00 | 是 | General Counsel |
| 2025-03-05 | Taub Rebecca |
|
46.10 | 0.00 | 是 | Pres., R&D, and CMO |
| 2025-03-03 | Huntsman Carole |
|
1.02 | 314.74 | 是 | Chief Commercial Officer |
| 2025-03-03 | Huntsman Carole |
|
0.99 | 320.21 | 是 | Chief Commercial Officer |
| 2025-03-03 | Huntsman Carole |
|
0.97 | 323.65 | 是 | Chief Commercial Officer |
| 2025-03-03 | Huntsman Carole |
|
0.95 | 324.59 | 是 | Chief Commercial Officer |
| 2025-03-03 | Huntsman Carole |
|
0.94 | 326.34 | 是 | Chief Commercial Officer |
| 2025-03-03 | Huntsman Carole |
|
0.93 | 327.49 | 是 | Chief Commercial Officer |
| 2025-03-03 | Huntsman Carole |
|
0.92 | 329.64 | 是 | Chief Commercial Officer |
| 2025-03-03 | Huntsman Carole |
|
0.86 | 335.00 | 是 | Chief Commercial Officer |
| 2025-03-03 | Kelley Shannon T |
|
0.73 | 335.00 | 是 | General Counsel |
| 2025-03-03 | Dier Mardi |
|
0.77 | 325.89 | 是 | SVP and CFO |
| 2025-03-03 | Dier Mardi |
|
0.69 | 323.54 | 是 | SVP and CFO |
| 2025-02-28 | Waltermire Robert E. |
|
0.39 | 340.99 | 是 | Senior VP, Chief Pharma Dev. |
| 2025-02-28 | Waltermire Robert E. |
|
0.37 | 341.55 | 是 | Senior VP, Chief Pharma Dev. |
| 2025-02-27 | Daly James M |
|
1.14 | 65.06 | 是 | -- |
| 2025-02-27 | Daly James M |
|
1.74 | 111.06 | 是 | -- |
| 2025-02-27 | Daly James M |
|
1.70 | 346.90 | 是 | -- |
| 2025-02-27 | Daly James M |
|
0.27 | 347.39 | 是 | -- |
| 2025-02-27 | Daly James M |
|
0.19 | 348.94 | 是 | -- |
| 2025-02-27 | BATE KENNETH |
|
0.79 | 111.06 | 是 | -- |
| 2025-02-27 | BATE KENNETH |
|
1.74 | 65.06 | 是 | -- |
| 2025-02-27 | BATE KENNETH |
|
2.19 | 9.45 | 是 | -- |
| 2025-02-27 | BATE KENNETH |
|
2.18 | 351.01 | 是 | -- |
| 2025-02-27 | BATE KENNETH |
|
2.13 | 351.99 | 是 | -- |
| 2025-02-27 | BATE KENNETH |
|
2.11 | 353.83 | 是 | -- |
| 2025-02-27 | BATE KENNETH |
|
1.25 | 355.08 | 是 | -- |
| 2025-02-27 | BATE KENNETH |
|
0.97 | 356.51 | 是 | -- |
| 2025-02-27 | BATE KENNETH |
|
0.77 | 357.27 | 是 | -- |
| 2025-02-27 | BATE KENNETH |
|
0.42 | 358.33 | 是 | -- |
| 2025-02-27 | BATE KENNETH |
|
0.21 | 359.21 | 是 | -- |
| 2025-02-27 | BATE KENNETH |
|
0.19 | 360.07 | 是 | -- |
| 2025-02-27 | Sibold William John |
|
10.43 | -- | 是 | President and CEO |
| 2025-01-24 | Taub Rebecca |
|
45.67 | 335.24 | 是 | Pres., R&D, and CMO |
| 2025-01-24 | Waltermire Robert E. |
|
0.50 | 335.24 | 是 | Senior VP, Chief Pharma Dev. |
| 2025-01-24 | Huntsman Carole |
|
1.04 | 335.24 | 是 | Chief Commercial Officer |
| 2025-01-24 | Sibold William John |
|
5.43 | 335.24 | 是 | President and CEO |
| 2025-01-17 | Taub Rebecca |
|
45.73 | 273.41 | 是 | Pres., R&D, and CMO |
| 2025-01-17 | Waltermire Robert E. |
|
0.51 | 273.41 | 是 | Senior VP, Chief Pharma Dev. |
| 2025-01-17 | Kelley Shannon T |
|
0.77 | 273.41 | 是 | General Counsel |
| 2024-11-21 | Huntsman Carole |
|
1.08 | 316.92 | 是 | Chief Commercial Officer |
| 2024-11-07 | Levy Richard S |
|
1.60 | 7.36 | 是 | -- |
| 2024-11-07 | Levy Richard S |
|
1.10 | 350.00 | 是 | -- |
| 2024-11-01 | Levy Richard S |
|
1.60 | 7.36 | 是 | -- |
| 2024-11-01 | Levy Richard S |
|
1.32 | 300.10 | 是 | -- |
| 2024-11-01 | Levy Richard S |
|
1.21 | 301.22 | 是 | -- |
| 2024-11-01 | Levy Richard S |
|
1.13 | 302.25 | 是 | -- |
| 2024-11-01 | Levy Richard S |
|
1.10 | 304.29 | 是 | -- |
| 2024-09-13 | CRAVES FRED B |
|
36.01 | 0.00 | 是 | -- |
| 2024-09-09 | Sibold William John |
|
5.59 | 243.83 | 是 | President and CEO |
| 2024-08-15 | Kelley Shannon T |
|
0.80 | 0.00 | 是 | General Counsel |
| 2024-06-25 | FRIEDMAN PAUL A |
|
18.64 | 0.00 | 是 | -- |
| 2024-06-25 | Levy Richard S |
|
1.10 | 0.00 | 是 | -- |
| 2024-06-25 | Daly James M |
|
0.19 | 0.00 | 是 | -- |
| 2024-06-25 | BATE KENNETH |
|
0.19 | 0.00 | 是 | -- |
| 2024-06-25 | CRAVES FRED B |
|
37.51 | 0.00 | 是 | -- |
| 2024-06-14 | Waltermire Robert E. |
|
0.74 | 87.09 | 是 | Senior VP, Chief Pharma Dev. |
| 2024-06-14 | Waltermire Robert E. |
|
0.55 | 280.00 | 是 | Senior VP, Chief Pharma Dev. |
| 2024-06-12 | Waltermire Robert E. |
|
0.75 | 87.92 | 是 | Senior VP, Chief Pharma Dev. |
| 2024-06-12 | Waltermire Robert E. |
|
0.55 | 285.00 | 是 | Senior VP, Chief Pharma Dev. |
| 2024-06-11 | CRAVES FRED B |
|
37.44 | 0.00 | 是 | -- |
| 2024-05-21 | Waltermire Robert E. |
|
0.55 | 231.34 | 是 | Senior VP, Chief Pharma Dev. |
| 2024-05-14 | CRAVES FRED B |
|
42.34 | 100.45 | 是 | -- |
| 2024-05-14 | CRAVES FRED B |
|
43.59 | 105.08 | 是 | -- |
| 2024-05-14 | CRAVES FRED B |
|
42.70 | 210.99 | 是 | -- |
| 2024-05-14 | CRAVES FRED B |
|
42.20 | 211.84 | 是 | -- |
| 2024-05-14 | CRAVES FRED B |
|
42.07 | 212.85 | 是 | -- |
| 2024-05-14 | CRAVES FRED B |
|
41.85 | 213.85 | 是 | -- |
| 2024-05-14 | CRAVES FRED B |
|
41.67 | 214.68 | 是 | -- |
| 2024-05-14 | CRAVES FRED B |
|
41.63 | 216.08 | 是 | -- |
| 2024-05-14 | CRAVES FRED B |
|
41.56 | 216.98 | 是 | -- |
| 2024-05-14 | CRAVES FRED B |
|
41.45 | 217.86 | 是 | -- |
| 2024-05-14 | CRAVES FRED B |
|
41.35 | 218.99 | 是 | -- |
| 2024-05-14 | CRAVES FRED B |
|
41.34 | 219.90 | 是 | -- |
| 2024-04-08 | FRIEDMAN PAUL A |
|
21.20 | 9.45 | 是 | -- |
| 2024-04-08 | FRIEDMAN PAUL A |
|
21.06 | 242.95 | 是 | -- |
| 2024-04-08 | FRIEDMAN PAUL A |
|
20.68 | 244.12 | 是 | -- |
| 2024-04-08 | FRIEDMAN PAUL A |
|
20.12 | 244.86 | 是 | -- |
| 2024-04-08 | FRIEDMAN PAUL A |
|
19.91 | 245.71 | 是 | -- |
| 2024-04-08 | FRIEDMAN PAUL A |
|
19.41 | 246.96 | 是 | -- |
| 2024-04-08 | FRIEDMAN PAUL A |
|
19.06 | 247.76 | 是 | -- |
| 2024-04-08 | FRIEDMAN PAUL A |
|
18.57 | 248.59 | 是 | -- |
| 2024-04-08 | Taub Rebecca |
|
46.17 | 9.45 | 是 | Pres., R&D, and CMO |
| 2024-04-08 | Taub Rebecca |
|
46.15 | 243.25 | 是 | Pres., R&D, and CMO |
| 2024-04-08 | Taub Rebecca |
|
46.05 | 244.79 | 是 | Pres., R&D, and CMO |
| 2024-04-08 | Taub Rebecca |
|
46.02 | 245.69 | 是 | Pres., R&D, and CMO |
| 2024-04-08 | Taub Rebecca |
|
45.96 | 246.98 | 是 | Pres., R&D, and CMO |
| 2024-04-08 | Taub Rebecca |
|
45.92 | 247.76 | 是 | Pres., R&D, and CMO |
| 2024-04-08 | Taub Rebecca |
|
45.90 | 248.58 | 是 | Pres., R&D, and CMO |
| 2024-04-03 | FRIEDMAN PAUL A |
|
21.31 | 9.45 | 是 | -- |
| 2024-04-03 | FRIEDMAN PAUL A |
|
21.30 | 242.00 | 是 | -- |
| 2024-04-03 | FRIEDMAN PAUL A |
|
21.07 | 243.64 | 是 | -- |
| 2024-04-03 | FRIEDMAN PAUL A |
|
20.64 | 244.58 | 是 | -- |
| 2024-04-03 | FRIEDMAN PAUL A |
|
18.76 | 245.34 | 是 | -- |
| 2024-04-03 | FRIEDMAN PAUL A |
|
18.57 | 246.31 | 是 | -- |
| 2024-04-03 | FRIEDMAN PAUL A |
|
20.44 | 9.45 | 是 | -- |
| 2024-04-03 | FRIEDMAN PAUL A |
|
19.82 | 241.07 | 是 | -- |
| 2024-04-03 | FRIEDMAN PAUL A |
|
19.29 | 242.25 | 是 | -- |
| 2024-04-03 | FRIEDMAN PAUL A |
|
19.14 | 243.00 | 是 | -- |
| 2024-04-03 | FRIEDMAN PAUL A |
|
19.08 | 244.31 | 是 | -- |
| 2024-04-03 | FRIEDMAN PAUL A |
|
18.82 | 245.14 | 是 | -- |
| 2024-04-03 | FRIEDMAN PAUL A |
|
18.67 | 246.13 | 是 | -- |
| 2024-04-03 | FRIEDMAN PAUL A |
|
18.59 | 247.14 | 是 | -- |
| 2024-04-03 | FRIEDMAN PAUL A |
|
18.57 | 248.43 | 是 | -- |
| 2024-04-03 | FRIEDMAN PAUL A |
|
21.33 | 9.45 | 是 | -- |
| 2024-04-03 | FRIEDMAN PAUL A |
|
21.19 | 240.10 | 是 | -- |
| 2024-04-03 | FRIEDMAN PAUL A |
|
21.13 | 241.15 | 是 | -- |
| 2024-04-03 | FRIEDMAN PAUL A |
|
20.46 | 242.42 | 是 | -- |
| 2024-04-03 | FRIEDMAN PAUL A |
|
19.54 | 243.20 | 是 | -- |
| 2024-04-03 | FRIEDMAN PAUL A |
|
19.14 | 244.22 | 是 | -- |
| 2024-04-03 | FRIEDMAN PAUL A |
|
18.62 | 245.35 | 是 | -- |
| 2024-04-03 | FRIEDMAN PAUL A |
|
18.57 | 245.92 | 是 | -- |
| 2024-04-03 | Taub Rebecca |
|
48.68 | 9.45 | 是 | Pres., R&D, and CMO |
| 2024-04-03 | Taub Rebecca |
|
48.67 | 242.00 | 是 | Pres., R&D, and CMO |
| 2024-04-03 | Taub Rebecca |
|
48.41 | 243.68 | 是 | Pres., R&D, and CMO |
| 2024-04-03 | Taub Rebecca |
|
48.00 | 244.68 | 是 | Pres., R&D, and CMO |
| 2024-04-03 | Taub Rebecca |
|
46.11 | 245.34 | 是 | Pres., R&D, and CMO |
| 2024-04-03 | Taub Rebecca |
|
45.90 | 246.32 | 是 | Pres., R&D, and CMO |
| 2024-04-03 | Taub Rebecca |
|
47.75 | 9.45 | 是 | Pres., R&D, and CMO |
| 2024-04-03 | Taub Rebecca |
|
47.33 | 240.88 | 是 | Pres., R&D, and CMO |
| 2024-04-03 | Taub Rebecca |
|
46.77 | 241.85 | 是 | Pres., R&D, and CMO |
| 2024-04-03 | Taub Rebecca |
|
46.46 | 242.71 | 是 | Pres., R&D, and CMO |
| 2024-04-03 | Taub Rebecca |
|
46.42 | 244.01 | 是 | Pres., R&D, and CMO |
| 2024-04-03 | Taub Rebecca |
|
46.15 | 245.06 | 是 | Pres., R&D, and CMO |
| 2024-04-03 | Taub Rebecca |
|
45.98 | 246.01 | 是 | Pres., R&D, and CMO |
| 2024-04-03 | Taub Rebecca |
|
45.91 | 247.23 | 是 | Pres., R&D, and CMO |
| 2024-04-03 | Taub Rebecca |
|
45.90 | 248.23 | 是 | Pres., R&D, and CMO |
| 2024-04-03 | Taub Rebecca |
|
48.65 | 9.45 | 是 | Pres., R&D, and CMO |
| 2024-04-03 | Taub Rebecca |
|
48.49 | 240.11 | 是 | Pres., R&D, and CMO |
| 2024-04-03 | Taub Rebecca |
|
48.42 | 241.14 | 是 | Pres., R&D, and CMO |
| 2024-04-03 | Taub Rebecca |
|
47.53 | 242.61 | 是 | Pres., R&D, and CMO |
| 2024-04-03 | Taub Rebecca |
|
46.64 | 243.33 | 是 | Pres., R&D, and CMO |
| 2024-04-03 | Taub Rebecca |
|
46.43 | 244.45 | 是 | Pres., R&D, and CMO |
| 2024-04-03 | Taub Rebecca |
|
45.90 | 245.53 | 是 | Pres., R&D, and CMO |
| 2024-04-01 | Daly James M |
|
2.12 | 100.45 | 是 | -- |
| 2024-04-01 | Daly James M |
|
2.28 | 105.08 | 是 | -- |
| 2024-04-01 | Daly James M |
|
1.60 | 255.64 | 是 | -- |
| 2024-04-01 | Daly James M |
|
0.86 | 256.50 | 是 | -- |
| 2024-04-01 | Daly James M |
|
0.50 | 257.30 | 是 | -- |
| 2024-04-01 | Daly James M |
|
0.35 | 258.28 | 是 | -- |
| 2024-04-01 | Daly James M |
|
0.33 | 259.11 | 是 | -- |
| 2024-04-01 | Daly James M |
|
0.25 | 262.01 | 是 | -- |
| 2024-04-01 | Daly James M |
|
0.23 | 263.31 | 是 | -- |
| 2024-04-01 | Daly James M |
|
0.20 | 264.89 | 是 | -- |
| 2024-04-01 | Daly James M |
|
0.15 | 265.49 | 是 | -- |
| 2024-04-01 | Daly James M |
|
0.12 | 266.91 | 是 | -- |
| 2024-04-01 | Daly James M |
|
1.21 | 105.08 | 是 | -- |
| 2024-04-01 | Daly James M |
|
1.13 | 243.26 | 是 | -- |
| 2024-04-01 | Daly James M |
|
0.50 | 244.19 | 是 | -- |
| 2024-04-01 | Daly James M |
|
0.20 | 244.89 | 是 | -- |
| 2024-04-01 | Daly James M |
|
0.14 | 246.30 | 是 | -- |
| 2024-04-01 | Daly James M |
|
0.12 | 248.45 | 是 | -- |
| 2024-04-01 | BATE KENNETH |
|
1.12 | 9.45 | 是 | -- |
| 2024-04-01 | BATE KENNETH |
|
2.12 | 100.45 | 是 | -- |
| 2024-04-01 | BATE KENNETH |
|
2.25 | 105.08 | 是 | -- |
| 2024-04-01 | BATE KENNETH |
|
1.58 | 255.62 | 是 | -- |
| 2024-04-01 | BATE KENNETH |
|
0.84 | 256.49 | 是 | -- |
| 2024-04-01 | BATE KENNETH |
|
0.56 | 257.33 | 是 | -- |
| 2024-04-01 | BATE KENNETH |
|
0.35 | 258.24 | 是 | -- |
| 2024-04-01 | BATE KENNETH |
|
0.33 | 259.13 | 是 | -- |
| 2024-04-01 | BATE KENNETH |
|
0.24 | 262.18 | 是 | -- |
| 2024-04-01 | BATE KENNETH |
|
0.23 | 263.08 | 是 | -- |
| 2024-04-01 | BATE KENNETH |
|
0.22 | 264.73 | 是 | -- |
| 2024-04-01 | BATE KENNETH |
|
0.15 | 265.36 | 是 | -- |
| 2024-04-01 | BATE KENNETH |
|
0.12 | 266.91 | 是 | -- |
| 2024-04-01 | BATE KENNETH |
|
1.24 | 105.08 | 是 | -- |
| 2024-04-01 | BATE KENNETH |
|
1.12 | 243.28 | 是 | -- |
| 2024-04-01 | BATE KENNETH |
|
0.41 | 244.27 | 是 | -- |
| 2024-04-01 | BATE KENNETH |
|
0.21 | 244.97 | 是 | -- |
| 2024-04-01 | BATE KENNETH |
|
0.15 | 246.20 | 是 | -- |
| 2024-04-01 | BATE KENNETH |
|
0.14 | 246.88 | 是 | -- |
| 2024-04-01 | BATE KENNETH |
|
0.12 | 248.49 | 是 | -- |
| 2024-04-01 | Levy Richard S |
|
1.53 | 7.36 | 是 | -- |
| 2024-04-01 | Levy Richard S |
|
1.06 | 265.28 | 是 | -- |
| 2024-04-01 | Levy Richard S |
|
2.13 | 111.06 | 是 | -- |
| 2024-04-01 | Levy Richard S |
|
1.69 | 255.90 | 是 | -- |
| 2024-04-01 | Levy Richard S |
|
1.30 | 256.88 | 是 | -- |
| 2024-04-01 | Levy Richard S |
|
1.14 | 257.93 | 是 | -- |
| 2024-04-01 | Levy Richard S |
|
1.13 | 259.07 | 是 | -- |
| 2024-04-01 | Levy Richard S |
|
1.03 | 267.07 | 是 | -- |
| 2024-01-23 | Sibold William John |
|
6.23 | 0.00 | 是 | President and CEO |
| 2024-01-23 | Lynch Brian Joseph |
|
1.77 | 0.00 | 是 | SVP and General Counsel |
| 2024-01-23 | Howarth Alex G. |
|
1.87 | 0.00 | 是 | Chief Financial Officer |
| 2024-01-23 | Waltermire Robert E. |
|
0.65 | 0.00 | 是 | Senior VP, Chief Pharma Dev. |
| 2024-01-23 | Taub Rebecca |
|
2.08 | 0.00 | 是 | Pres., R&D, and CMO |
| 2024-01-23 | Huntsman Carole |
|
1.15 | 0.00 | 是 | Chief Commercial Officer |
| 2024-01-16 | Howarth Alex G. |
|
1.39 | 243.92 | 是 | Chief Financial Officer |
| 2024-01-16 | Waltermire Robert E. |
|
0.51 | 243.92 | 是 | Senior VP, Chief Pharma Dev. |
| 2024-01-16 | Taub Rebecca |
|
1.50 | 243.92 | 是 | Pres., R&D, and CMO |
| 2024-01-16 | Lynch Brian Joseph |
|
1.41 | 243.92 | 是 | SVP and General Counsel |